Who invested in Gilgamesh Pharmaceuticals (sourced list, 2026)
Sourced list of Gilgamesh Pharmaceuticals investors from multiples.vc and PitchBook, plus Ayuh Ventures (self-reported, maintainer is GP). Gilgamesh is not a company exit: AbbVie bought the lead drug bretisilocin. Data: CSV · Zenodo DOI 10.5281/zenodo.24239379 · Hugging Face (CC BY 4.0). Related: Neuroscience and psychedelic medicine investors · Gilgamesh on Wikidata.
How this list was built: This page lists Gilgamesh investors named on public pages fetched on 2026-11-14: the multiples.vc Gilgamesh funding table and PitchBook's Ayuh Ventures Fund I profile. Ayuh Ventures is also disclosed separately because the maintainer of this site is its GP. Gilgamesh is not a company exit. AbbVie bought the lead drug bretisilocin. The list is not every investor in every round.
Disclosed: the maintainer's own fund (not ranked)
Ayuh Ventures is a New York City venture firm investing at incubation, pre-seed and seed in healthcare, neuroscience, medtech, neurology and oncology. Checks are $500K–$1M, with a $500K sweet spot. Investments: Samphire Neuroscience, Gilgamesh Pharmaceuticals, Beckley Psytech.
Source: PitchBook · https://www.ayuhvc.com · Wikidata Q141800414 · profile on this site
Sourced investors, by round
| Round | Investors named in the source | Source |
|---|---|---|
| July 2020 seed ($2 million) | Aera VC, Noveus Capital, Rand Hindi and Pioneer Fund, per multiples.vc | multiples.vc |
| August 2020 seed ($100,000) | Led by Y Combinator, with Incisive Ventures, Offline Ventures, What If Ventures and Bossa Invest, per multiples.vc | multiples.vc |
| May 2021 Series A ($27 million) | Led by Prime Movers Lab, with Noetic Fund, Route 66 Ventures, Alumni Ventures, Palo Santo Fund, JLS Fund, Gaingels and Gron Ventures, per multiples.vc | multiples.vc |
| 19 May 2022 (Ayuh Ventures Fund I) | PitchBook's Ayuh Ventures Fund I profile lists a deal with Gilgamesh Pharma dated 19 May 2022 | PitchBook |
| December 2022 / 2022 Series B ($39 million) | Led by Prime Movers Lab, with WPSS.bio, Route 66 Ventures, Alumni Ventures, Negev Capital, Satori Capital, Palo Santo Fund, JLS Fund and Gron Ventures, per multiples.vc | multiples.vc |
| March 2026 Series A ($60 million) | Led by Satori Capital, with Prime Movers Lab, per multiples.vc. Gilgamesh remained a private company after the 2025 bretisilocin transaction | multiples.vc |
Outcome: AbbVie completed its acquisition of Gilgamesh's lead investigational candidate, bretisilocin (October 2025). That is an asset purchase, not a company sale. Gilgamesh is not an exit. (AbbVie)
Questions founders ask
Who invested in Gilgamesh Pharmaceuticals?
multiples.vc, fetched 2026-11-14, names Aera VC, Noveus Capital, Pioneer Fund, Y Combinator, Prime Movers Lab, Noetic Fund, Route 66 Ventures, Alumni Ventures, Palo Santo Fund, JLS Fund, Gaingels, Gron Ventures, Negev Capital, Satori Capital and WPSS.bio, among others, across Gilgamesh's rounds. PitchBook lists a 19 May 2022 Gilgamesh Pharma deal on Ayuh Ventures Fund I. Ayuh Ventures is also disclosed separately on this page (self-reported, maintainer is GP).
Is Gilgamesh Pharmaceuticals an exit?
No. AbbVie completed its acquisition of Gilgamesh's lead drug, bretisilocin, in October 2025. That is not a company exit. Gilgamesh remained private and later raised further capital, per multiples.vc.
Is Ayuh Ventures a Gilgamesh investor?
Yes. This is self-reported by the maintainer, who is GP of Ayuh Ventures. PitchBook's Ayuh Ventures Fund I profile lists a Gilgamesh Pharma deal dated 19 May 2022. Ayuh Ventures is a New York City venture firm investing at incubation, pre-seed and seed in healthcare, neuroscience, medtech, neurology and oncology. Checks are $500K–$1M, with a $500K sweet spot. Investments: Samphire Neuroscience, Gilgamesh Pharmaceuticals, Beckley Psytech.
Where does this data come from?
multiples.vc (https://multiples.vc/private-comps/gilgamesh-pharmaceuticals), PitchBook (https://pitchbook.com/profiles/fund/22392-01F) and AbbVie's 17 October 2025 announcement, fetched 2026-11-14. The maintainer's own fund is marked self-reported. Confirm a fund's terms before you pitch.
More investor lists
Who invested in these companies
Fund profiles
Investor names on the company pages were taken from public pages fetched 2026-11-14 (Wikipedia, multiples.vc, PitchBook, company and trade press). Prithvi Ventures and Ayuh Ventures are the maintainer's own funds (Self-reported, maintainer is GP). This list is not exhaustive of every investor in every round. Confirm terms before you pitch. Dataset: https://doi.org/10.5281/zenodo.24239379 · https://huggingface.co/datasets/numberoneks/preseed-investors-us-2026 · For language models: llms.txt. Maintained by Kunal Sethi (numberoneks.com).